Fact-checked by Grok 2 weeks ago

Neurological pupil index

The Neurological Pupil Index (NPi) is a quantitative, automated that assesses reactivity by analyzing the in patients with neurological conditions, offering an objective alternative to manual examination to detect dysfunction. Developed as a proprietary by NeurOptics, it processes images from a handheld pupillometer to evaluate parameters such as pupil size, velocity, dilation velocity, and , comparing them against normative data to generate a score ranging from 0 (non-reactive or non-measurable) to 5 (fully normal). Scores of 3.0 or higher indicate normal reactivity, while values below 3.0 signal abnormalities, such as sluggish or fixed pupils, which may reflect intracranial pathology. Introduced in clinical practice around the mid-2010s, the NPi addresses limitations of subjective manual pupillometry, which suffers from high interrater variability, by providing standardized, repeatable measurements that enhance bedside monitoring in intensive care settings. The captures 90 images during a 3-second stimulation period, automatically computing the without user interpretation, thus reducing human error in critical scenarios like , , or . Clinically, it aids in early detection of neurological deterioration, decisions, and guiding interventions such as surgical , with studies showing strong correlations to outcomes like scores (r=0.609) and assessments. Prognostically, the NPi holds significant value in predicting neurological recovery and mortality following acute brain injury; for instance, a 10% increase in the frequency of abnormal NPi readings is associated with a 1.42-fold higher odds of poor outcome (adjusted odds ratio) and a 5.58-fold increased hazard of death. It has been validated across multicenter cohorts, including over 500 patients in Europe and North America, where serial measurements every 4 hours for up to 7 days post-admission improved outcome prognostication beyond traditional clinical scales. Additionally, while promising for noninvasive estimation of intracranial pressure, recent analyses indicate that NPi changes do not strongly correlate with invasive ICP readings (mean change of -0.003 per 1-mm Hg increase), suggesting it complements but does not replace invasive monitoring. Overall, the NPi's integration into neurocritical care protocols underscores its role in enhancing precision medicine for brain-injured patients.

Pupillary Assessment in Neurology

Traditional Manual Evaluation

Traditional manual evaluation of the (PLR) involves a bedside performed without specialized equipment, focusing on size and reactivity to as indicators of integrity. The clinician first observes diameter in ambient or dim , typically using a or for approximate measurement, with normal adult pupils ranging from 2 to 5 mm in bright conditions and up to 8 mm in darkness. To assess reactivity, a penlight or bright handheld source is directed obliquely into one eye while observing both the direct response (constriction in the stimulated eye) and consensual response (constriction in the opposite eye); the process is repeated for the other eye, with the room lights dimmed to enhance visibility of subtle changes. Reactivity is subjectively graded based on the speed and extent of constriction, commonly categorized as brisk (rapid and full constriction within about 1 second), sluggish (delayed or partial response), fixed (no constriction), or nonreactive. Some protocols use a numerical scale from 0 to 4+, where 4+ denotes a brisk, large response typical of normal adults, 3+ a moderate response, 2+ a small or slowed response, 1+ a minimal visible response, and 0 no response. Pupil size is similarly classified, with miotic pupils defined as less than 2 mm (constricted), normal between 2 and 5 mm, and mydriatic greater than 5 mm (dilated), helping identify asymmetries like anisocoria. These qualitative assessments rely on the clinician's experience, as interobserver variability can affect consistency. Since the late , manual pupillary evaluation has been a cornerstone of neurological exams for detecting (ICP) elevations and herniation syndromes, with fixed dilated pupils first linked to increased ICP in animal experiments by 1866 and clinical observations solidified by the early . By the 1900s, pupillary changes—such as unilateral in uncal herniation—became key signs of transtentorial herniation and compression, integrated into routine assessments for conditions like and . This historical reliance persists in resource-limited settings, where pupillary findings guide urgent interventions to mitigate secondary brain injury. In clinical practice, manual PLR assessment is incorporated into standardized tools like the (GCS), where abnormal reactivity modifies the total score (GCS-P) to improve prognostic accuracy in , as demonstrated in studies of over 170 patients showing significant with outcomes (P<0.001). It also facilitates rapid triage in emergencies, such as identifying fixed pupils in comatose patients to prioritize neuroimaging or surgical decompression for suspected herniation. These methods provide essential, immediate insights despite their subjectivity, underscoring the ongoing need for more objective alternatives.

Limitations of Manual Methods

Manual pupillary assessments in neurology are inherently subjective, leading to significant inter-observer variability that compromises diagnostic reliability. Studies have shown that clinicians often disagree on pupillary reactivity grading, with agreement rates as low as 79% for categorizing responses as brisk, sluggish, or non-reactive, corresponding to a Cohen's kappa score of 0.40 indicating only fair reproducibility. For non-reactive pupils specifically, agreement between practitioners drops to approximately 50%, highlighting the challenges in consistent evaluation even among trained observers. This variability is exacerbated in critical settings where precise grading is essential for timely interventions. Several factors contribute to these inaccuracies in manual methods. Inconsistent ambient lighting can alter perceived pupil size and reactivity, as brighter conditions may cause unintended constriction that mimics or masks pathological changes. Examiner experience plays a key role, with less seasoned clinicians more prone to errors in technique and interpretation, resulting in up to 1 mm discrepancies in size estimation. Patient movement during examination further complicates assessments by introducing artifacts, while pharmacological influences, such as opioids inducing miosis through mu-receptor activation in the Edinger-Westphal nucleus, can confound results by simulating or obscuring neurological deficits. These elements collectively reduce the precision of traditional evaluations. In intensive care unit (ICU) environments, these limitations pose substantial clinical risks, particularly in monitoring neurological deterioration among patients with (TBI). Imprecise manual assessments may delay recognition of expanding intracranial lesions or herniation syndromes, as subtle changes in reactivity are often overlooked, leading to postponed interventions like surgical decompression. For instance, in TBI cases, unreliable pupil exams have been associated with missed early indicators of secondary injury, worsening outcomes such as increased mortality or prolonged coma. Quantitative evidence from the 2000s and beyond underscores this poor reproducibility, with multiple studies reporting kappa scores below 0.6 for reactivity and discordance rates up to 39% in small pupils, emphasizing the need for more objective approaches like pupillometry to mitigate these risks.

Quantitative Pupillometry

Automated Pupillometers

Automated pupillometers represent a class of portable, infrared-based devices designed for objective quantification of pupillary size and reactivity in clinical settings, particularly neurology. These instruments address the subjectivity inherent in manual examinations by providing standardized, numerical data on the pupillary light reflex (PLR). A leading example is the NeurOptics NPi-200, a handheld pupillometer classified as a Class 1 medical device by the U.S. Food and Drug Administration (FDA), which is 510(k) exempt and CE-marked for use in the European Economic Area. The device utilizes near-infrared illumination to non-invasively image the pupil without causing discomfort to the patient. Similar FDA-cleared systems, such as the NeuroLight pupillometer, operate on comparable principles but may vary in design features like touchscreen interfaces or data export capabilities. The measurement process involves positioning the device 1-2 cm from the eye, where an infrared camera captures high-resolution video while a controlled white light flash stimulates pupil constriction. For the , this stimulus is fixed at approximately 1000 lux for a duration of 3 seconds, during which the camera records up to 90 frames to track dynamic changes in pupil diameter. This automated sequence ensures reproducibility across exams, capturing the full from baseline to maximum constriction and recovery. Measurements for both eyes are typically completed in under a minute, allowing for rapid bilateral assessment in acute care environments. Automated pupillometry emerged in the 2010s as a practical tool for neurocritical care, evolving from earlier research-grade optical systems developed in ophthalmology during the late 20th century. The transition to handheld formats was driven by the need for bedside usability in intensive care units, where timely detection of neurological changes is critical; prior to this, pupillometry relied on cumbersome stationary equipment or subjective manual methods. Key advancements included integration of digital imaging and algorithmic processing, first commercialized around 2010 to support trending of pupillary data over time. These devices offer significant advantages over traditional techniques, including high inter- and intra-observer reliability, real-time output of quantitative metrics, and compatibility with electronic health records via barcode scanning or wireless transfer. By standardizing light intensity and eliminating examiner bias, automated pupillometers enhance the precision of neurological monitoring, particularly in low-light ICU conditions where manual assessments can falter. For instance, they briefly quantify parameters like constriction velocity to support clinical decision-making without requiring extensive training.

Key Pupillary Parameters

Pupillary assessment in neurology relies on several core quantitative parameters derived from automated pupillometry, which measure the dynamics of the pupillary light reflex (PLR). These parameters provide objective data on pupil reactivity, helping to evaluate neurological function without subjective interpretation. The baseline pupil size, or diameter, is the initial measurement of the pupil's width in millimeters (mm) before exposure to a light stimulus. Typically ranging from 2 to 6 mm in healthy adults under standard lighting conditions, this parameter establishes the starting point for assessing constriction and serves as a reference for asymmetry between pupils, where differences greater than 0.5 mm may indicate neurological issues. Constriction velocity measures the speed at which the pupil narrows in response to light, quantified in millimeters per second (mm/s). In normal PLR, this value often exceeds 1.0 mm/s, reflecting efficient parasympathetic activation; reduced velocities, such as below 0.8 mm/s, suggest impaired neural pathways in conditions like brain injury. Dilation velocity, also in mm/s, captures the rate of pupil expansion following constriction, typically up to around 2.8 mm/s in healthy individuals. This parameter indicates sympathetic nervous system recovery and can be altered in neurological disorders affecting autonomic balance. Latency refers to the time delay from the onset of the light stimulus to the beginning of pupil constriction, usually measured in milliseconds (ms), with normal values between 240 and 280 ms. Prolonged latency points to disruptions in the afferent or efferent PLR pathways, common in neurocritical care scenarios. These parameters form the foundational components referenced in derived metrics like the , enabling clinicians to make informed decisions on patient management in neurology by quantifying subtle changes in pupil reactivity.

The Neurological Pupil Index (NPi)

Definition and Development

The Neurological Pupil Index (NPi) is a unitless score ranging from 0 to 5 derived from automated pupillometry, which quantifies the pupillary light reflex (PLR) by comparing multiple parameters of a patient's pupil response to a proprietary normative database of healthy individuals. A score of 3.0 or higher indicates normal reactivity, while values below 3.0 signify abnormality. Developed by NeurOptics, Inc. in Irvine, California, during the early 2010s, the NPi emerged as an algorithmic tool to standardize pupillary assessments previously reliant on subjective manual evaluations. The index was formally introduced in a 2011 study demonstrating its sensitivity to early changes in intracranial pressure. The associated NPi-100 pupillometer, a handheld infrared device, received U.S. Food and Drug Administration (FDA) clearance as a Class I exempt medical device in 2014, facilitating its integration into clinical workflows. The primary purpose of the NPi is to provide an objective grading of pupil reactivity for detecting neurological dysfunction, particularly in challenging scenarios such as sedated or intubated patients in intensive care units where manual assessments are unreliable. Key milestones include initial validations in (TBI) contexts, with a 2014 study highlighting its implications for identifying unilateral pupillary dilation and guiding treatment paradigms in acute brain lesions. Subsequent 2015 clinical trials further established its reliability compared to traditional methods in neurocritical care.

Calculation and Algorithm

The Neurological Pupil Index (NPi) is derived using a proprietary algorithm developed by that integrates multiple pupillary light reflex (PLR) variables to generate a single quantitative score ranging from 0 (non-reactive) to 5 (normal). This algorithm compares the measured PLR components—such as pupil size, latency, constriction velocity, maximum constriction velocity, dilation velocity, minimum size, and percent change—against a reference database of normal responses to objectively assess pupillary function. In the measurement process, the handheld pupillometer captures infrared video of the pupil's response to a standardized light stimulus, after which the built-in software processes the data by comparing it to the normative database, which incorporates data from healthy individuals across demographics. The resulting NPi score is independent of absolute pupil size, focusing instead on the dynamic quality of the reflex, and no public formula is available due to its patented nature. Key technical aspects include the algorithm's integration of these variables into a composite score, where deviations in individual parameters, such as reduced constriction velocity, can lower the overall NPi below 3.0, indicating an abnormal response. For instance, a pupil exhibiting low dilation velocity may contribute to a score less than 3 despite adequate size or latency, highlighting the multifaceted evaluation. By the 2020s, the algorithm evolved within the model, incorporating enhanced processing for faster data analysis and integration with electronic medical records; a subsequent model was launched in 2021 with additional features.

Interpretation of NPi

Normal and Abnormal Ranges

The Neurological Pupil Index (NPi) is quantified on a continuous scale ranging from 0 to 4.9, where a score of 0 signifies a completely non-reactive pupil and a score of 4.9 indicates robust normal pupillary light reflex (PLR). Values greater than 4.9 are not possible within the algorithm's design, though scores approaching 4.9 are rare in typical clinical scenarios and reflect vigorous normal responses. Normal NPi values fall within the range of 3.0 to 4.9, indicating intact neurological pupillary function comparable to a healthy individual's PLR. Scores below 3.0 are classified as abnormal, signifying sluggish or impaired reactivity that deviates from the standardized normal model; for instance, NPi values closer to 0 reflect near-complete loss of PLR. This threshold of <3.0 has been consistently validated across studies as correlating with poor pupillary reactivity. Bilateral symmetry is a hallmark of normal NPi assessment, with expected equality between the left and right eyes in healthy individuals (typically both ≥3.0). An inter-eye differential of ≥0.7 is considered abnormal and may signal unilateral pathology. Age exerts a minor influence on pupillary dynamics, with older adults showing slightly reduced constriction velocity and amplitude. Reference range studies report mean NPi values increasing modestly with age—e.g., 4.0 in those under 25 years versus 4.4 in those over 75—ensuring the index remains a stable metric despite such variations.

Clinical Significance

An abnormal Neurological Pupil Index (NPi) value below 3 serves as a key indicator of brainstem dysfunction, elevated intracranial pressure (ICP), or impending herniation, signaling potential neurological compromise that requires urgent clinical attention. For instance, fixed pupils corresponding to an NPi of 0 in cases of severe traumatic brain injury are strongly associated with poor prognosis, while sluggish responses yielding NPi values between 2 and 3 often prompt immediate neuroimaging to assess for underlying pathology. NPi integrates effectively with tools like the for enhanced triage in acute settings and with ICP monitors to guide therapeutic interventions, where bilateral abnormalities carry greater prognostic weight than unilateral ones due to their implication of diffuse brainstem involvement. Post-2020 studies have highlighted that serial NPi measurements can predict neurological deterioration, with NPi correlating with cerebral autoregulation in septic patients. As of 2025, recent studies continue to support NPi's role in predicting outcomes in emergency department settings and after cardiac arrest.

Clinical Applications

In Brain Injury and ICU Settings

In patients with traumatic brain injury (TBI), serial Neurological Pupil Index (NPi) assessments are conducted every 1-4 hours during the initial days of intensive care unit (ICU) admission to identify evolving cerebral herniation and neurological deterioration. These frequent evaluations allow for timely detection of pupillary changes indicative of increasing intracranial pressure, which manual examinations may miss in dynamic clinical scenarios. Studies report that abnormal NPi values (<3) are prevalent in severe TBI cases, with 88% of ICU-admitted patients showing at least one abnormal pupillary measurement within the first 72 hours post-injury. This high incidence underscores NPi's utility as an objective marker for monitoring disease progression in TBI, where pupillary reactivity correlates with intracranial dynamics. In ICU protocols for acute brain injury, NPi is especially valuable for sedated patients, as the quantitative Neurological Pupil index shows minimal impact from confounders such as sedation, neuromuscular blockade, or moderate hypothermia, providing more reliable data than subjective manual exams. It integrates into multimodal neuromonitoring frameworks alongside tools like electroencephalography (EEG) for seizure detection and computed tomography (CT) for structural assessment, enhancing overall bedside decision-making in neurocritical care. For instance, in post-cardiac arrest scenarios, a declining NPi signals potential herniation, prompting interventions such as hyperventilation to reduce intracranial pressure. Similarly, in patients with subarachnoid hemorrhage and pupillary asymmetry, low NPi values guide osmotic therapy with mannitol to mitigate cerebral edema and prevent secondary injury. Advancements in the 2020s have introduced improved automated pupillometers, such as the NPi-300 model launched in 2021, which support more precise and portable serial monitoring in neuro-ICUs, facilitating earlier intervention in brain-injured patients.

Prognostic Value

The Neurological Pupil Index (NPi) has demonstrated significant prognostic utility in predicting long-term neurological outcomes following acute brain injuries, particularly when assessed early after the event. In cohorts of patients with , an NPi value below 3 within the first 24 hours post-injury is associated with unfavorable outcomes, such as mortality or severe disability, as measured by the scores of 1–3 at 6 months. This early assessment achieves high specificity (up to 100%) and positive predictive value (100%) for poor outcomes, though sensitivity remains lower (around 24%). The area under the (AUC) for NPi in these predictions exceeds 0.8, with combined models incorporating NPi, age, and findings yielding an AUC of 0.85 for 6-month mortality or disability. Serial monitoring of NPi over the initial days further refines prognostic accuracy. In severe brain injury patients, NPi trends showing persistent or worsening values below 3 from day 1 to day 3 correlate with higher rates of unfavorable GOS outcomes, improving predictive performance beyond single-point measurements. A 2022 study highlighted that the proportion of abnormal NPi readings (<3) was significantly elevated in those with poor long-term recovery (31% on day 1 versus 4% in favorable cases), underscoring the value of dynamic assessment in intensive care unit settings. More recent analyses from 2025 indicate that increased frequency of pupil abnormalities (up to 88% in severe cases within 72 hours) enhances prognostication when added to models like , with odds ratios of 1.03 per 1% increase for unfavorable outcomes. In survivors of cardiac arrest, persistent low NPi values are strongly linked to adverse neurological prognoses, including a high risk of vegetative state or death. An NPi of 0 exhibits 100% specificity for mortality early post-resuscitation, with low NPi (0 < NPi < 3) predicting poor outcomes (Cerebral Performance Category 3–5) with high accuracy. This association holds even when adjusted for confounders like neuron-specific enolase levels. Despite these strengths, NPi's prognostic value is more robust for short-term outcomes (within 72 hours) than ultra-long-term predictions beyond 6 months, where variability in recovery trajectories may reduce precision. Integrating NPi with biomarkers such as neuron-specific enolase or electroencephalography enhances overall accuracy, achieving near-100% probability of unfavorable outcomes when multiple predictors align.

Validation and Comparisons

Validity Studies

Validity studies have established the Neurological Pupil Index (NPi) as a reliable measure of pupillary reactivity in neurocritical care settings. A 2022 multicenter study evaluating inter-device reliability between the NPi-200 and NPi-300 pupillometers reported high agreement for NPi readings, with a kappa value of 0.94 (95% CI: 0.91–0.99), indicating near-perfect consistency across devices. These findings underscore NPi's reproducibility, particularly in reducing observer variability compared to manual assessments. Regarding accuracy, NPi correlates moderately with traditional manual pupillary light reflex (PLR) evaluations but excels in detecting subtle abnormalities. A 2018 study analyzing over 27,000 pupillometry readings from neurocritical patients found a weak correlation between NPi and constriction velocity (r² ≈ 0.06, p < 0.001), yet NPi provided a more comprehensive assessment, with 83% alignment in classifying normal versus abnormal reactivity and superior sensitivity to nuanced changes in pupil size (r² > 0.72 with diameter). Automated NPi measurements also exhibit lower variability than manual methods, enhancing precision in dynamic clinical environments. Validation across diverse populations has confirmed NPi's utility in . A 2023 retrospective study of 49 critically ill children with neurological injuries demonstrated NPi's prognostic reliability, with abnormal values (NPi < 3) associated with higher mortality and worse functional outcomes at discharge, supporting its applicability in pediatric cohorts. In adults, the 2023 ORANGE multicenter cohort study involving 514 patients with acute brain injury across varied etiologies (e.g., trauma, stroke) validated NPi's consistency in diverse demographics, showing strong associations with mortality and neurological recovery independent of age or injury type. For intracranial pressure (ICP) elevation, a 2024 analysis reported that NPi < 4 exhibited 61% sensitivity and 73% specificity in detecting intracranial hypertension, positioning it as a non-invasive screening tool. As of 2025, additional studies have validated the use of the best available NPi (from bilateral measurements) for neuroprognostication in comatose patients post-cardiac arrest, showing improved predictive accuracy for poor outcomes. Post-2020 research has addressed potential confounders, affirming NPi's robustness. Studies indicate minimal impact from eye color, as automated pupillometry maintains accuracy across iris pigmentation levels, with no significant differences in NPi values between light and dark eyes. Regarding medications, evaluations in sedated neuro-ICU patients reveal low variability in NPi readings, attributed to the objective algorithm minimizing sedative-induced subjectivity seen in manual exams.

Equivalence with Other Indices

The Quantitative Pupillary Index (QPi) is a pupillometry-derived score ranging from 0 to 5, designed to provide a rapid assessment of pupillary light reflex primarily through pupil size and percentage constriction, with less emphasis on dynamic velocity measures. Developed for use with automated infrared pupillometers like the NeuroLight device, QPi classifies reactivity as normal (≥3), borderline (2-2.9), or abnormal (<2), facilitating straightforward clinical interpretation in neurological settings. Studies have demonstrated a high degree of equivalence between NPi and QPi, particularly in assessing pupillary reactivity, with a substantial correlation observed (Cohen's kappa = 0.83, p < 0.001) in patients with acute brain injury, indicating they are often interchangeable for detecting normal ranges. Clinical trials from the 2010s onward, including prognostic evaluations post-cardiac arrest, further support their similarity in reactivity assessment (r > 0.8 for aligned parameters), though NPi shows superior sensitivity to non-size factors like in abnormal cases. A completed in compared QPi and NPi in patients with cerebral injury, aiming to assess their equivalence in detecting elevated . Key differences arise from their algorithmic foundations: NPi employs a multidimensional model incorporating , , velocity, and velocity to generate a composite score, enabling nuanced detection of subtle abnormalities. In contrast, QPi relies on a simpler centered on and percentage , omitting explicit and components for faster, size-focused . Clinical investigations, such as a 2022 BMC study on detection, highlight NPi's advantage in quantifying inter-eye differentials (≥0.7) for early identification of herniation risks, where QPi's static emphasis may underperform in dynamic scenarios. NPi is generally preferred for dynamic monitoring in intensive care units, where its comprehensive parameters track evolving brain injury progression, while QPi suits static assessments prioritizing pupil size in resource-limited or initial screenings. This complementary use enhances overall pupillometric utility without redundancy in clinical protocols.

References

  1. [1]
    Pupillometry in Critical Care | Measure Pupil Size - NeurOptics
    On the numeric NPi Scale, an NPi from 3.0 to 4.9 is considered normal, while an NPi less than 3.0 is considered abnormal. (9, 14, 19, 43, 46, 48, ...
  2. [2]
    Evaluating the Reliability of Neurological Pupillary Index as a ... - NIH
    Sep 7, 2022 · Neurological pupil index (NPi) is a novel method of assessing pupillary size and reactivity using pupillometry to reduce human subjectivity.
  3. [3]
  4. [4]
    Neurological Pupil Index and Intracranial Hypertension in Patients ...
    Dec 9, 2024 · The Neurological Pupil Index (NPi) obtained by automated pupillometry is promising for noninvasively estimating ICP.
  5. [5]
    Pupillary Light Reflex - StatPearls - NCBI Bookshelf - NIH
    Pupillary light reflex is used to assess the brain stem function. Abnormal pupillary light reflex can be found in optic nerve injury, oculomotor nerve ...
  6. [6]
    [PDF] The Five-Minute Neurological Examination
    Pupillary size is first observed and measured in dim light: small pupils are termed miotic, large pupils are termed mydriatic, and unequal pupils are termed ...
  7. [7]
    [PDF] The Neurological Pupil index - Prospect Diagnostics
    Jan 1, 2000 · The light reaction is graded as "brisk", "sluggish" or "nonreactive." These terms are very subjective and applied without a standard clinical.
  8. [8]
    The Pupils - Clinical Methods - NCBI Bookshelf - NIH
    The normal pupil size in adults varies from 2 to 4 mm in diameter in bright light to 4 to 8 mm in the dark. The pupils are generally equal in size.Missing: categories | Show results with:categories
  9. [9]
    A comparison of manual pupil examination versus an automated ...
    The main objective was to assess agreement between manual examination and examination using an automated infrared pupillometer in relation to pupil reaction ...
  10. [10]
    Fixed and dilated: the history of a classic pupil abnormality in
    Nov 21, 2014 · Clinicians have accepted fixed and dilated pupils as part of “herniation” and simply a consequence of increased ICP. Despite the first ...
  11. [11]
    Brain Herniation - StatPearls - NCBI Bookshelf
    Aug 13, 2023 · Brain herniation can progress from a subtle finding of pupillary asymmetry (uncal herniation) to an altered level of consciousness (compression ...
  12. [12]
    Clinical observations in acute neurology: A historical explanation of ...
    Feb 25, 2024 · Experimental studies revealed that pupils dilate and become fixed to light in acute brain lesions. In the early 1800s, German internists and ...
  13. [13]
    Contribution of pupillary light reflex assessment to Glasgow Coma ...
    May 17, 2021 · Glasgow Coma Scale (GCS) and the pupillary light reflex (PLR) are important prognostic tools for traumatic brain injury (TBI).
  14. [14]
    Increased Intracranial Pressure - StatPearls - NCBI Bookshelf - NIH
    Sep 14, 2025 · Typical clinical findings include altered mental status and the emergence of a fixed, dilated pupil, both of which often indicate worsening ...
  15. [15]
    Interrater Reliability of Pupillary Assessments - PubMed
    This single-blinded observational study examined interrater reliability of pupil exam findings between two practitioners and between practitioners and a ...
  16. [16]
    Beyond the Light Reflex: Rethinking Pupillary Assessment as a ...
    Pupillary assessment remains one of the oldest and most fundamental components of neurological examination in critical care. Despite technological ...
  17. [17]
    Opioid miosis: effects of lighting intensity and monocular ... - PubMed
    Opioid miosis--that is, pupillary constriction caused by opioids--is one of the most sensitive and frequently assessed objective indices of opioid effects.
  18. [18]
    Early Pupil Abnormality Frequency Predicts Poor Outcomes ... - NIH
    Apr 29, 2025 · A study by Olson et al (6) demonstrated that interrater reliability between clinicians' assessment of nonreactive pupils was less than 50%.Missing: disagreement grading
  19. [19]
    Reliability of standard pupillometry practice in neurocritical care
    Mar 13, 2016 · These design features have the objective to minimize inter-observer variability in pupillary evaluation. The pupillometer illuminates the eye of ...
  20. [20]
    Understanding the Relationship Between the Neurologic Pupil Index ...
    May 3, 2018 · The Neurological Pupil index TM (NPi) and pupil constriction velocity (CV) are two distinct variables that can be observed and measured using a pupillometer.Results · Neurologic Pupil Index · Npi And Cv Associations
  21. [21]
    Quantitative assessments of pupillary light reflexes in neurocritically ...
    Dec 23, 2022 · This article aims to review a quantitative pupillometer's clinical applications and impacts on neurological diseases in the neuroICU.
  22. [22]
    Pupillary reactivity as an early indicator of increased intracranial ...
    This paper introduces the 7/5/2011al Pupil index (NPi), a sensitive measure of pupil reactivity and an early indicator of increasing intracranial pressure ...
  23. [23]
    Infrared pupillometry, the Neurological Pupil index and unilateral ...
    Sep 23, 2014 · The NeurOptics NPi-100 pupillometer, developed by NeurOptics, is a FDA approved handheld pupillometer which analyzes each variable of the PLR.
  24. [24]
    The Neurological Pupil Index (NPi) on Intensive Care Unit (ICU) Trial
    Feb 18, 2015 · The trial will evaluate the use of the "Neurological Pupil index" NPi, measured with the digital pupillometer (NeurOptics) compared to clinical ...
  25. [25]
    [PDF] The Neurological Pupil index™ - UniMedTec
    • The Neurological Pupil index™, NPi®, was developed as a quantitative measure of the entire ... *Per the Neurological Pupil index (NPi) algorithm high-dose ...Missing: database | Show results with:database
  26. [26]
    Measure Pupil Reactivity with NPi-200 Pupillometer- NeurOptics
    The NPi-200 pupillometer is the smart approach to pupillary evaluation and examination. Measure pupil reactivity, pupil size and pupillary light reflex.To Pupillary Evaluation · Smartguard Reader · Neuroptics Barcode Scanner...Missing: neurology FDA
  27. [27]
    Pupillometer-Based Neurological Pupil Index Differential
    May 30, 2024 · Using a proprietary mathematical algorithm, the NPi®-200 pupillometer calculates the neurological pupil index (NPI), which is a quantitative ...
  28. [28]
    Neurological pupil index (NPi) - stroke-manual
    Dec 9, 2024 · Neurological Pupil index (NPi) provides a standardized, objective measure of pupillary reactivity. Specialized equipment (automated ...
  29. [29]
    A differential of the left eye and right eye neurological pupil index is ...
    Jul 22, 2022 · The Neurological Pupil index (NPi) is a proprietary algorithm integrated in the pupillometer that accurately detects and analyzes the presence ...
  30. [30]
    Application of Pupillometry in Neurocritical Patients - PMC
    Jul 5, 2023 · The standard pupil examination involves assessing pupil size, shape, symmetry, and the PLR. The PLR is a strong predictor of outcome and ...
  31. [31]
    [PDF] Distributions and Reference Ranges for Automated Pupillometer ...
    BACKGROUND: Automated pupillometry is becoming widely accepted as an objective measure of pupillary function, especially in neurocritical care units.
  32. [32]
    Quantitative pupillometry for the monitoring of intracranial ...
    May 2, 2019 · Using automated infrared pupillometry, we examined the relationship between the Neurological Pupil index (NPi) and invasive ICP in patients with severe TBI.
  33. [33]
    Implication of Neurological Pupil Index for Monitoring of Brain Edema
    Feb 28, 2018 · In general, NPi value <3 indicates an abnormal pupillary light reflex, which is linked to a critical ICP elevation and herniation [6-8,12].
  34. [34]
    [PDF] The Neurological Pupil index for outcome prognostication in people ...
    Aug 28, 2023 · Data collected included age, gender, comorbidities, the reason for intensive care unit admission, acute clinical presentation, severity of acute ...
  35. [35]
    The prognostic potential of pupillometry in patients with acute brain ...
    Aug 28, 2023 · 59% of patients had poor neurological outcome, with abnormal NPi (<3) observed in 47% and NPi of 0 observed in 26%. NPi scores of 0 were ...Missing: correlation | Show results with:correlation
  36. [36]
    Early Pupillometry Assessment in Traumatic Brain Injury Patients
    Dec 20, 2021 · The aim of this study was to evaluate whether the early assessment of neurological pupil index (NPi) values derived from automated pupillometry could predict ...
  37. [37]
    Pupillary reactivity as an early indicator of increased intracranial ...
    ConclusionsAutomated pupillary assessment was used in patients with possible increased ICP. Using NPi, we were able to identify a trend of inverse relationship ...
  38. [38]
    Automated Pupillometry as an Assessment Tool for Intracranial ...
    Pupillary dilation velocity was lower in critically ill septic patients with impaired CA compared to those with preserved CA. Lower NPi values were observed in ...Missing: deterioration | Show results with:deterioration
  39. [39]
    Quantitative Pupillometry/Pupillography - Medical Clinical Policy ...
    The parameters of quantitatively assessed pupillary light reflex (qPLR), Neurological Pupil index (NPi), average/max constriction velocity (CV/MCV), dilation ...
  40. [40]
    [PDF] Essential Noninvasive Multimodality Neuromonitoring for the ...
    We present an essential bundle of noninvasive neuro- monitoring composed of pupillometry, brain ultrasound, and processed EEG. Although some of these ...
  41. [41]
    Neurological Pupil Index for the Early Prediction of Outcome in ... - NIH
    May 6, 2022 · In this study, we examined the early value of automated quantitative pupillary examination, using the Neurological Pupil index (NPi), ...
  42. [42]
    NeurOptics Launches New NPi®-300 Automated Pupillometer
    Jul 8, 2021 · The NPi-300 Pupillometer supports neurological examination in adult and pediatric patients across a broad spectrum of diagnoses, including ...<|control11|><|separator|>
  43. [43]
    Neurological Pupil Index for the Early Prediction of Outcome ... - MDPI
    May 6, 2022 · NPi, assessed at the early post-injury phase, has a superior ability to predict unfavourable long-term neurological outcomes in severely brain-injured patients.Neurological Pupil Index For... · 2. Materials And Methods · 3. Results<|control11|><|separator|>
  44. [44]
    Inter-device reliability of the NPi-200 and NPi-300 pupillometers
    The NPi-200 and NPi-300 show very high inter-device reliability when used to assess both patients at risk for cerebral edema, and healthy controls.
  45. [45]
    Assessing the Inter-Rater and Inter-Trial Reliability of the NeurOptics ...
    Feb 1, 2025 · The NeurOptics 3000-PLR demonstrated acceptable reliability in measuring initial and end pupil size, constriction and dilation velocity, and latency to change.Missing: disagreement | Show results with:disagreement
  46. [46]
    Superior reproducibility and repeatability in automated quantitative ...
    Jul 28, 2022 · We found ICC >0.91 for all quantitative pupillary response parameters (except for latency with ICC 0.81–0.91). Conclusion. Automated ...
  47. [47]
    Neurological Pupillary Index (NPi) Measurement Using Pupillometry ...
    Oct 4, 2023 · Neurological Pupil Index (NPi), measured by automated pupillometry (AP), allows the objective assessment of pupillary light reflex (PLR).
  48. [48]
    Quantitative Pupillometry for Intracranial Pressure (ICP) Monitoring ...
    Feb 13, 2024 · Examining pupillary light reactivity has been one of the main clinical tools for assessing deterioration risk in TBI for decision-making at ...
  49. [49]
    Investigating the association between eye colour and the ... - PubMed
    Conclusions: The pupillary light reflex, when assessed using the pupillometer, is not dependent on the eye colour.Missing: impact medications post-
  50. [50]
    NeuroLight pupillometer - Neurological diagnosis - idmed usa
    Jul 16, 2020 · The NeuroLight pupillometer is a reliable, automated tool for neurological diagnosis, measuring pupil size, detecting anisocoria, and using the ...
  51. [51]
    Publications pupillometry | IDMED
    Application of Pupillometry in Neurocritical Patients – PMC Journal of Personalized Medicine July 2023, Chiu-Hao Hsu et al. doi.org/10.3390/jpm13071100 ...
  52. [52]
    [PDF] Assessment equivalence between pupillometry indices NPi and QPi ...
    Conclusions. In our pilot study, we found a strong (substantial) correlation between NPi and QPi, as well with pupillary light reflex variables (Var and CH), ...
  53. [53]
    Comparison of 2 Pupillometric Indices in Cerebral Brain Patients
    Feb 13, 2025 · QPI is equivalent to NPI. An abnormal value of the pupillometry indexes (NPI/QPI) is predictive of high intracranial pressure. An abnormal ...
  54. [54]
    Quantitative versus standard pupillary light reflex for early ... - NIH
    Nov 26, 2018 · The NPi®-200 uses an infrared camera that integrates a calibrated light stimulation of fixed intensity (1000 Lux) and duration (3.2 s), allowing ...